Supplemental material
Original Article
Comparison of the GPVI inhibitors losartan and honokiol
, , , , , , , 
, & show all
Natalie S. PoulterInstitute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlandshttps://orcid.org/0000-0002-3187-2130View further author information
https://orcid.org/0000-0002-3187-2130View further author information, & Steve P WatsonInstitute of Cardiovascular Sciences, IBR Building, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK;Centre of Membrane Proteins and Receptors (COMPARE), Universities of Birmingham and Nottingham, The Midlandshttps://orcid.org/0000-0002-7846-7423View further author information
https://orcid.org/0000-0002-7846-7423View further author information show allRelated Research Data
Use of Synthetic Peptides to Locate Novel Integrin α2β1-binding Motifs in Human Collagen III
Source:
Elsevier BV
Platelets and primary haemostasis.
Source:
Elsevier BV
Characterization of the in vivo antiplatelet activity of the antihypertensive agent losartan.
Source:
SAGE Publications
Expression and Function of the Mouse Collagen Receptor Glycoprotein VI Is Strictly Dependent on Its Association with the FcRγ Chain
Source:
American Society for Biochemistry & Molecular Biology (ASBMB)
High-throughput elucidation of thrombus formation reveals sources of platelet function variability.
Source:
Ferrata Storti Foundation (Haematologica)
Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation.
Source:
American Society of Hematology
Losartan: Comprehensive Profile.
Source:
Elsevier
Neuroprotective effects of honokiol
Source:
Wiley
Platelet ITAM signaling.
Source:
Ovid Technologies (Wolters Kluwer Health)
Platelet glycoprotein VI: its structure and function
Source:
Elsevier BV
Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies.
Source:
Springer Science and Business Media LLC
Natural Products for the Treatment of Type 2 Diabetes Mellitus
Source:
Georg Thieme Verlag KG
CD28 Mediates Transcriptional Upregulation of the Interleukin-2 (IL-2) Promoter through a Composite Element Containing the CD28RE and NF-IL-2B AP-1 Sites
Source:
American Society for Microbiology
Discovery of Novel GPVI Receptor Antagonists by Structure-Based Repurposing
Source:
Public Library of Science (PLoS)
Linking provided by
